SCHEMBL14440916

SCHEMBL14440916

C[C@@]1(O)[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1n1ccc2c(Cl)nc(N)nc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 3/20 0.46
▸ LMNA P02545 2/20 0.41
▸ MTOR P42345 2/20 0.41
▸ THRB P10828 1/20 0.41
▸ MDM2 Q00987 1/20 0.41
▸ NCOA1 Q15788 1/20 0.41
▸ NCOA3 Q9Y6Q9 1/20 0.41
▸ ADA P00813 1/20 0.39
▸ SLC29A1 Q99808 7/20 0.39
▸ PDE4D Q08499 1/20 0.39
▸ PDE3A Q14432 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ ADORA3 P0DMS8 4/20 0.38
▸ ADORA1 P30542 3/20 0.38
▸ ADORA2B P29275 2/20 0.37
▸ ALOX15 P16050 1/20 0.37
▸ GMNN O75496 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ TP53 P04637 1/20 0.36
▸ NFKB1 P19838 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1737904 0.93 ADORA2A (0.53) ADORA2ALMNAMTORTHRBMDM2
SCHEMBL6730328 0.93 ADORA2A (0.53) ADORA2ALMNAMTORTHRBMDM2
SCHEMBL14440600 0.83 ADORA2A (0.47) ADORA2AADORA3
SCHEMBL14440914 0.82 PNP (0.45) ADORA2ALMNAMTORTHRBMDM2
SCHEMBL12154572 0.82 ADORA2A (0.53) ADORA2AADASLC29A1PDE4DPDE3A
SCHEMBL474846 0.82 ADORA2A (0.53) ADORA2AADASLC29A1PDE4DPDE3A
SCHEMBL12150880 0.82 ADORA2A (0.53) ADORA2AADASLC29A1PDE4DPDE3A
SCHEMBL12031227 0.82 ADORA2A (0.53) ADORA2AADASLC29A1PDE4DPDE3A
SCHEMBL6729928 0.82 LMNA (0.58) LMNAMTORTHRBMDM2NCOA1
SCHEMBL1737343 0.82 LMNA (0.58) LMNAMTORTHRBMDM2NCOA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070185063-A1 Seven-membered ring nucleosides IDENIX PHARMACEUTICALS, INC. 2007-08-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070185063-A1 Seven-membered ring nucleosides NSUN2, NSUN3, HAVCR2 ADORA2A 566/4885LMNA 1658/4885MTOR 1448/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback